Kheng Newick

3.0k total citations · 3 hit papers
15 papers, 2.4k citations indexed

About

Kheng Newick is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Kheng Newick has authored 15 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Kheng Newick's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Kheng Newick is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (5 papers). Kheng Newick collaborates with scholars based in United States, Germany and United Kingdom. Kheng Newick's co-authors include Edmund K. Moon, Steven Μ. Albelda, Shaun O’Brien, Albert Lo, Carl H. June, Jing Sun, Ellen Puré, Xiaojun Liu, Yangbing Zhao and Soyeon Kim and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kheng Newick

15 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CAR T Cell Therapy for Solid Tumors

2016 663 citations Kheng Newick, Shaun O’Brien et al. Annual Review of Medicine profile →
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

2016 420 citations Xiaojun Liu, Raghuveer Ranganathan et al. Cancer Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by Kheng Newick

Since Specialization

Citations

This map shows the geographic impact of Kheng Newick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kheng Newick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kheng Newick more than expected).

Fields of papers citing papers by Kheng Newick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kheng Newick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kheng Newick. The network helps show where Kheng Newick may publish in the future.

Co-authorship network of co-authors of Kheng Newick

This figure shows the co-authorship network connecting the top 25 collaborators of Kheng Newick. A scholar is included among the top collaborators of Kheng Newick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kheng Newick. Kheng Newick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors breakdown → 2016 ·Cancer Research ·Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon	420
2	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization 2016 ·Cancer Immunology Research ·Kheng Newick, Shaun O’Brien, Jing Sun, Veena Kapoor, (unknown), Albert Lo, Ellen Puré, Edmund K. Moon, Steven Μ. Albelda	160
3	Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity 2016 ·EBioMedicine ·Liqing Wang, Suresh Kumar, Satinder Dahiya, Feng Wang, Jian Wu, Kheng Newick, Rongxiang Han, Arabinda Samanta, Ulf H. Beier, Tatiana Akimova, Tricia Bhatti, Benjamin Nicholson, (unknown), Saket Agarwal, David E. Sterner, Wei Gu, Joseph Weinstock, Tauseef R. Butt, Steven Μ. Albelda, Wayne W. Hancock	91
4	Chimeric antigen receptor T-cell therapy for solid tumors 2016 ·Molecular Therapy — Oncolytics ·Kheng Newick, Edmund K. Moon, Steven Μ. Albelda	184
5	CAR T Cell Therapy for Solid Tumors breakdown → 2016 ·Annual Review of Medicine ·Kheng Newick, Shaun O’Brien, Edmund K. Moon, Steven Μ. Albelda	663
6	Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors 2015 ·Cancer Immunology Research ·Enxiu Wang, Liang-Chuan Wang, Ching‐Yi Tsai, Vijay Bhoj, (unknown), Edmund K. Moon, Kheng Newick, Jing Sun, Albert Lo, Timothy Baradet, Michael D. Feldman, David M. Barrett, Ellen Puré, Steven Albelda, Michael C. Milone	91
7	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer 2015 ·Clinical Cancer Research ·Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O’Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven Μ. Albelda	96
8	Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma 2015 ·PLoS ONE ·Brian Cunniff, Kheng Newick, Kimberly Nelson, (unknown), Stacie L. Beuschel, Bruce J. Leavitt, (unknown), Kelly J. Butnor, Andreas Koenig, Edward T. Chouchani, Andrew M. James, (unknown), W. Todd Lowther, Michael P. Murphy, Arti Shukla, Nicholas H. Heintz	26
9	Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells breakdown → 2015 ·Cancer Research ·Albert Lo, Liang‐Chuan S. Wang, John Scholler, James Monslow, Diana Avery, Kheng Newick, Shaun O’Brien, Rebecca A. Evans, David J. Bajor, Cynthia Clendenin, Amy C. Durham, Elizabeth L. Buza, Robert H. Vonderheide, Carl H. June, Steven Μ. Albelda, Ellen Puré	407
10	HDAC5 controls the functions of Foxp3⁺ T‐regulatory and CD8⁺ T cells 2015 ·International Journal of Cancer ·Haiyan Xiao, Jing Jiao, Liqing Wang, Shaun O’Brien, Kheng Newick, Liang‐Chuan S. Wang, (unknown), Yujie Liu, Rongxiang Han, Veena Kapoor, Finn K. Hansen, Thomas Kurz, Wayne W. Hancock, Ulf H. Beier	62
11	Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients 2013 ·OncoImmunology ·James Stevenson, Hedy L. Kindler, Emmanouil Papasavvas, Jing Sun, (unknown), Jennifer J. Hull, (unknown), Anjana Ranganathan, Kheng Newick, Daniel F. Heitjan, Corey J. Langer, John M. McPherson, Luis J. Montaner, Steven Μ. Albelda	65
12	Mitochondrial‐targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells 2012 ·Journal of Cellular Physiology ·Brian Cunniff, (unknown), Jason Stumpff, Kheng Newick, Paul Held, Douglas J. Taatjes, Joy Joseph, Balaraman Kalyanaraman, Nicholas H. Heintz	35
13	Peroxiredoxin 3 Is a Redox-Dependent Target of Thiostrepton in Malignant Mesothelioma Cells 2012 ·PLoS ONE ·Kheng Newick, Brian Cunniff, (unknown), Paul Held, Jack L. Arbiser, Harvey I. Pass, Brooke T. Mossman, Arti Shukla, Nicholas H. Heintz	46
14	Non-specific DNA binding interferes with the efficient excision of oxidative lesions from chromatin by the human DNA glycosylase, NEIL1 2009 ·DNA repair ·Ian D. Odell, Kheng Newick, Nicholas H. Heintz, Susan S. Wallace, David S. Pederson	48
15	Using BioTek's Synergy™ HT Reader to Measure Reactive Oxygen Species (ROS) Generation in Stimulated Cells 2009 ·BioTechniques ·Paul Held, Kheng Newick	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact